- Home
- ACXP vs TRAW Comparison
ACXP vs TRAW Comparison
Compare ACXP & TRAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACXP
- TRAW
- Stock Information
- Founded
- ACXP 2017
- TRAW 1998
- Country
- ACXP United States
- TRAW United States
- Employees
- ACXP N/A
- TRAW N/A
- Industry
- ACXP Biotechnology: Pharmaceutical Preparations
- TRAW
- Sector
- ACXP Health Care
- TRAW
- Exchange
- ACXP Nasdaq
- TRAW NYSE
- Market Cap
- ACXP 8.4M
- TRAW 7.8M
- IPO Year
- ACXP 2021
- TRAW 2013
- Fundamental
- Price
- ACXP $0.38
- TRAW $1.13
- Analyst Decision
- ACXP Strong Buy
- TRAW
- Analyst Count
- ACXP 2
- TRAW 0
- Target Price
- ACXP $10.00
- TRAW N/A
- AVG Volume (30 Days)
- ACXP 142.6K
- TRAW 128.9K
- Earning Date
- ACXP 05-13-2025
- TRAW 05-15-2025
- Dividend Yield
- ACXP N/A
- TRAW N/A
- EPS Growth
- ACXP N/A
- TRAW N/A
- EPS
- ACXP N/A
- TRAW N/A
- Revenue
- ACXP N/A
- TRAW $226,000.00
- Revenue This Year
- ACXP N/A
- TRAW $3.81
- Revenue Next Year
- ACXP N/A
- TRAW $30.43
- P/E Ratio
- ACXP N/A
- TRAW N/A
- Revenue Growth
- ACXP N/A
- TRAW N/A
- 52 Week Low
- ACXP $0.30
- TRAW $1.32
- 52 Week High
- ACXP $3.33
- TRAW $19.44
- Technical
- Relative Strength Index (RSI)
- ACXP 46.83
- TRAW 25.72
- Support Level
- ACXP $0.36
- TRAW $0.97
- Resistance Level
- ACXP $0.43
- TRAW $1.54
- Average True Range (ATR)
- ACXP 0.03
- TRAW 0.18
- MACD
- ACXP 0.00
- TRAW 0.02
- Stochastic Oscillator
- ACXP 37.55
- TRAW 20.24
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.
About TRAW TRAWS PHARMA INC
Traws Pharma Inc is a clinical-stage biopharmaceutical company dedicated to developing novel therapies to target critical threats to human health in respiratory viral diseases. It is advancing novel investigational antiviral agents that have potent activity against difficult-to-treat or resistant virus strains that threaten human health. Its product candidates are Tivoxavir marboxil, Ratutrelvir, and Narazaciclib.